Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer
N.V. Rajeshkumar(Johns Hopkins University), Manuel Hidalgo(Hospital Universitario de Fuenlabrada)
Cited by 51
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
A DNA methylation fingerprint of 1628 human samples
|Genome Research|2011|418
An <i>In vivo</i> Platform for Translational Drug Development in Pancreatic Cancer
|Clinical Cancer Research|2006|412